Total Payments
$2,576
2023 Payments
$30.17
Companies
31
Transactions
187
Medicare Patients
2,637
Medicare Billing
$263,971
Payment Breakdown by Category
Food & Beverage$2,473 (96.0%)
Education$102.85 (4.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,473 | 178 | 96.0% |
| Education | $102.85 | 9 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $327.50 | 25 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $276.09 | 21 | $0 (2019) |
| Amgen Inc. | $210.50 | 15 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $188.87 | 13 | $0 (2018) |
| GlaxoSmithKline, LLC. | $184.48 | 13 | $0 (2019) |
| Lilly USA, LLC | $180.35 | 14 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $158.44 | 11 | $0 (2019) |
| Merck Sharp & Dohme LLC | $145.10 | 11 | $0 (2023) |
| PFIZER INC. | $138.07 | 10 | $0 (2019) |
| Allergan Inc. | $124.13 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $30.17 | 2 | Merck Sharp & Dohme LLC ($16.19) |
| 2019 | $157.64 | 12 | EISAI INC. ($37.65) |
| 2018 | $948.06 | 70 | Amgen Inc. ($133.10) |
| 2017 | $1,440 | 103 | Novo Nordisk Inc ($173.89) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes Care | ||||||
| 05/04/2023 | Merck Sharp & Dohme LLC | M-M-R II (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: VACCINE | ||||||
| 09/10/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Diabetes | ||||||
| 06/06/2019 | Amgen Inc. | — | Education | In-kind items and services | $11.49 | General |
| 02/15/2019 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/08/2019 | PFIZER INC. | CHANTIX (Drug), LYRICA, COLOGUARD | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/06/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: RESPIRATORY | ||||||
| 01/24/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: RESPIRATORY | ||||||
| 01/17/2019 | EISAI INC. | Belviq (Drug) | Food and Beverage | Cash or cash equivalent | $13.85 | General |
| Category: Nutrition and Weight Loss | ||||||
| 01/17/2019 | EISAI INC. | Belviq (Drug) | Education | Cash or cash equivalent | $11.90 | General |
| Category: Nutrition and Weight Loss | ||||||
| 01/17/2019 | EISAI INC. | Belviq (Drug) | Education | Cash or cash equivalent | $11.90 | General |
| Category: Nutrition and Weight Loss | ||||||
| 01/11/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Respiratory | ||||||
| 01/04/2019 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/03/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Obesity | ||||||
| 12/27/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Virology & Specialty Care | ||||||
| 12/20/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/13/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, COLOGUARD | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/06/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Endocrinology | ||||||
| 11/16/2018 | Eisai Inc. | Belviq (Drug) | Food and Beverage | Cash or cash equivalent | $12.65 | General |
| Category: Nutrition and Weight Loss | ||||||
| 11/09/2018 | Eisai Inc. | Belviq (Drug) | Education | Cash or cash equivalent | $11.90 | General |
| Category: Nutrition and Weight Loss | ||||||
| 11/09/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: Diabetes | ||||||
| 11/08/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/02/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neuroscience | ||||||
| 10/26/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 732 | 911 | $241,755 | $80,898 |
| 2022 | 10 | 677 | 845 | $223,392 | $71,110 |
| 2021 | 11 | 568 | 700 | $189,997 | $57,697 |
| 2020 | 11 | 660 | 798 | $190,448 | $54,266 |
Total Patients
2,637
Total Services
3,254
Medicare Billing
$263,971
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 310 | $112,530 | $27,342 | 24.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 118 | 118 | $46,846 | $16,780 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 171 | $42,237 | $11,479 | 27.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 35 | 35 | $12,950 | $9,853 | 76.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 41 | 41 | $6,859 | $5,363 | 78.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 56 | 56 | $5,151 | $4,018 | 78.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 74 | 74 | $3,996 | $2,514 | 62.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 61 | $2,135 | $2,072 | 97.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $7,163 | $1,190 | 16.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 32 | $1,888 | $287.22 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 301 | $109,263 | $26,629 | 24.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 121 | 121 | $48,037 | $17,695 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 162 | $40,014 | $11,062 | 27.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 68 | 71 | $5,254 | $4,847 | 92.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 30 | 30 | $4,578 | $3,947 | 86.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 73 | 76 | $2,660 | $2,565 | 96.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $6,744 | $2,236 | 33.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 30 | 30 | $1,620 | $1,017 | 62.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 14 | $3,570 | $812.32 | 22.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 27 | 28 | $1,652 | $300.54 | 18.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 167 | 244 | $88,572 | $22,744 | 25.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 94 | 94 | $37,318 | $14,015 | 37.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 167 | $41,249 | $11,309 | 27.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 46 | 46 | $3,386 | $2,989 | 88.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $6,612 | $1,611 | 24.4% |
About Dr. Gary Kershner, DO
Dr. Gary Kershner, DO is a Family Medicine healthcare provider based in Union, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518937234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Kershner, DO has received a total of $2,576 in payments from pharmaceutical and medical device companies, with $30.17 received in 2023. These payments were reported across 187 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,473).
As a Medicare-enrolled provider, Kershner has provided services to 2,637 Medicare beneficiaries, totaling 3,254 services with total Medicare billing of $263,971. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Union, NJ
- Active Since 01/25/2006
- Last Updated 04/01/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1518937234
Products in Payments
- FARXIGA (Drug) $233.22
- Victoza (Drug) $167.25
- Prolia (Biological) $113.14
- Saxenda (Drug) $112.28
- TRULICITY (Drug) $110.08
- Belviq (Drug) $108.51
- CHANTIX (Drug) $101.26
- XARELTO (Drug) $99.38
- ANORO (Drug) $79.92
- JARDIANCE (Drug) $77.19
- INVOKANA (Drug) $71.44
- Repatha (Biological) $70.87
- TRADJENTA (Drug) $70.27
- BYSTOLIC (Drug) $66.50
- STIOLTO (Drug) $56.26
- SOLIQUA (Drug) $55.42
- SYMBICORT (Drug) $42.87
- JANUVIA (Drug) $40.05
- Myrbetriq (Drug) $39.86
- Vascepa (Drug) $38.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Union
Melonie Proctor, Do, DO
Family Medicine — Payments: $13,943
Family Medicine $13,943
Vincent Codella, Do, DO
Family Medicine — Payments: $11,857
Family Medicine $11,857
Dr. Brian Walters, Md, MD
Family Medicine — Payments: $7,966
Family Medicine $7,966
Dr. Corey Gallus, D.o, D.O
Family Medicine — Payments: $7,043
Family Medicine $7,043
Dr. Jamie Borgmann, Md, MD
Family Medicine — Payments: $6,904
Family Medicine $6,904
Michael Richardson, M.d, M.D
Family Medicine — Payments: $4,260
Family Medicine $4,260